Form 4: AnaptysBio Director Rita Jain Disposes of Shares and RSUs

Director Rita Jain disposed of common stock and restricted stock units of AnaptysBio on June 15, 2024, according to a Form 4 filing.

Summary

• On June 15, 2024, Rita Jain, a director of AnaptysBio, Inc. [ANAB], disposed of 4,534 shares of common stock.
• Additionally, Ms. Jain disposed of 3,234 and 1,300 restricted stock units (RSUs) on the same date.
• The RSUs represent a contingent right to receive shares of AnaptysBio's common stock upon settlement for no consideration.
• One set of RSUs vested 100% on the date of the Issuer's 2024 annual meeting of shareholders, while the other set vests in three equal installments on June 15, 2024, June 15, 2025, and June 15, 2026, subject to continued service to the company.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider trading activity.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders (directors, officers, or those holding 10% or more of a company's shares) buy or sell the company's securities. These filings provide transparency into insider transactions and can be monitored by investors for insights into management's perspective on the company's value and prospects.

Stakeholder Impact

• Shareholders may interpret the disposal of shares and RSUs by a director as a signal, although it could be for various personal financial reasons and not necessarily indicative of the company's performance.

Key Dates